NCT00217165View on ClinicalTrials.gov

Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

January 31, 2010

Study Completion Date

December 31, 2011

Conditions
Bipolar DisorderManiaBipolar Depression
Interventions
DRUG

taurine

taurine 2mg BID po

Trial Locations (1)

02478

McLean Hospital, Belmont

All Listed Sponsors
lead

Mclean Hospital

OTHER

NCT00217165 - Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study | Biotech Hunter | Biotech Hunter